 | This article uses bare URLs, which are uninformative and vulnerable to link rot. Please consider converting them to full citations to ensure the article remains verifiable and maintains a consistent citation style. Several templates and tools are available to assist in formatting, such as reFill (documentation) and Citation bot (documentation). (September 2022) (Learn how and when to remove this message) |
| Stephen Burley | |
|---|---|
| Born | 1958 (age 65–66) |
| Education | University of Western Ontario (BS) Exeter College, Oxford (MS, PhD) Harvard University (MD) |
| Scientific career | |
| Institutions | Rutgers University Lilly Research Laboratories Rockefeller University Howard Hughes Medical Institute |
| Thesis | Molecular arrangement in viruses studied by X-ray and neutron scattering and other physical techniques (1983) |
| Doctoral advisor | Andrew Miller |
Stephen Kevin Burley is a British-born scientist, naturalized in both Canada and the United States, specializing in oncology and structural biology. He is a University Professor and Henry Rutgers Chair at Rutgers, The State University of New Jersey. Burley directs the RCSB Protein Data Bank (a member of the Worldwide Protein Data Bank), the Center for Integrative Proteomics Research, and the Institute for Quantitative Biomedicine.
Career
Burley has a Bachelor in physics from the University of Western Ontario and a D.Phil from Oxford University, England in Molecular Biophysics as a Rhodes scholar. Burley has an M.D. from Harvard Medical School.
He worked with Gregory A. Petsko and William N. Lipscomb at MIT and Harvard. He was faculty at Howard Hughes Medical Institute and Rockefeller University. Burley co-founded Prospect Genomics, Inc, a computational genomics pharma. He was Chief Scientific Officer of SGX Pharmaceuticals after it acquired Prospect. SGX was in turn merged with Eli Lilly in 2008 where Burley was a Distinguished Lilly Research Scholar in Lilly Research Laboratories
In 2012 Burley joined Rutgers as Director of the Center for Integrative Proteomics Research and became director of the RCSB PDB (US regional data center for the worldwide PDB) in 2014, succeeding Prof. Helen Berman
He is a member of the Editorial Board for Oncogene.
Honors and awards
- Fellow of the Royal Society of Canada (elected 1995)
References
- "Structural GenomiX Appoints Stephen K. Burley as Chief Scientific Officer -- re> SAN DIEGO, Oct. 16 /PRNewswire/ --". Archived from the original on 2014-10-13.
- "Introducing Professor Stephen K. Burley | Department of Chemistry & Chemical Biology". Archived from the original on 2014-10-14. Retrieved 2014-10-08.
- "Stocks". 30 August 2023.
- http://proteomics.rutgers.edu/public/?q=faculty/burley
- "Rutgers recruits top researcher to head Center for Integrative Proteomics Research - NJBIZ". 17 December 2012.
- "RCSB PDB - News". www.rcsb.org. Archived from the original on 2014-09-03.
- "Editorial Board | Oncogene".